At 08:46 PM 8/31/2007 -0700, you wrote:
Protecting and monopolizing that investment must be what justifies the
suppression of competitive treatments.
## That's part of it, a pretty big part.
The FDA needs to get the out of the Pharms pocket.
The problem is: If the Pharm doesn't finance all their own testing as
required by the FDA like they do now, who will finance the FDA doing the
testing like they should be?
That would be the tax payer who doesn't want to foot the bill, as though,
they already aren't.
If the taxpayers suddenly realizes they ARE footing the bill..and then
some, then Alt Med gets a prayer of going legit.
Product testing will suddenly be affordable, but the number of tests will
skyrocket, thus, so will the bill.
Right now, Alt Med has an advantage of sorts. It can put just about any
BS out there with a disclaimer, so long as they don't make any claims.
It's a "blind eye" the FDA gives themselves and they use it, unless
somebody pokes their finger into it and grabs their attention.
Going legit would toss a whole bunch of kook-ies into the cutter.
..careful what you wish for, ey?
On the other side of the coin would be the Alt Patient.
Some common sense, dogged research and a lot of personal discrimination
is what that takes.
But who is left to sue when common sense is so..not common, and dogged
means to bark at somebody without discrimination?
Gulianni cleaned up NYC, but it lost a lot of it's illicit flavor in the
process. Kinda boring and safe these days.
Ode
--
No virus found in this outgoing message.
Checked by AVG Free Edition.
Version: 7.5.484 / Virus Database: 269.13.1/982 - Release Date: 8/31/2007 5:21 PM
--
The Silver List is a moderated forum for discussing Colloidal Silver.
Instructions for unsubscribing are posted at: http://silverlist.org
To post, address your message to: [email protected]
Address Off-Topic messages to: [email protected]
The Silver List and Off Topic List archives are currently down...
List maintainer: Mike Devour <[email protected]>
